Product Code: ETC6184459 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The magnetic resonance elastography market in Australia is gaining momentum due to its non-invasive approach to assessing tissue stiffness, particularly in the liver. MRE is becoming a preferred alternative to liver biopsies for diagnosing fibrosis and other chronic liver conditions. As the incidence of non-alcoholic fatty liver disease (NAFLD) and hepatitis increases in Australia, so does the demand for accurate and safe diagnostic methods. The growing focus on preventive healthcare and early disease detection is accelerating MRE adoption in both public and private hospitals. Additionally, ongoing R&D in imaging technologies is contributing to better accuracy, shorter scan times, and broader clinical applications of MRE. With an increase in awareness and accessibility, the Australian market is expected to grow steadily over the next few years.
The Magnetic Resonance Elastography (MRE) market in Australia is gaining traction as a non-invasive imaging technology for assessing tissue stiffness, especially in liver diagnostics. With rising liver disease cases and demand for early diagnosis, MRE is emerging as a preferred choice over traditional biopsies. Australian medical centers and research hospitals are increasingly investing in MRE-enabled MRI systems. Its adoption is also supported by patient demand for less invasive diagnostic alternatives. As awareness and reimbursement frameworks improve, the MRE market is likely to grow steadily across the public and private healthcare sectors.
The magnetic resonance elastography market in Australia is challenged by limited access to MRE-compatible MRI systems, which are available mostly in major metropolitan hospitals. Lack of awareness among physicians about the diagnostic value of MRE in conditions like liver fibrosis slows adoption. The procedures high cost and unclear reimbursement policies deter broader clinical use. Investment in upgrading MRI scanners with elastography software is expensive and slow. Patient acceptance is also limited, as many are unfamiliar with the technique compared to standard imaging. Moreover, competing non-invasive diagnostic methods like FibroScan present stiff competition.
Magnetic Resonance Elastography (MRE) is an advanced MRI technique that measures the stiffness of tissues and is used for assessing liver fibrosis, tumors, and other medical conditions. This non-invasive technology offers a significant advantage over traditional biopsy methods, making it a valuable tool in diagnostics. In Australia, the MRE market is expanding as healthcare providers seek non-invasive alternatives for diagnosing liver diseases, particularly in response to the rising prevalence of non-alcoholic fatty liver disease (NAFLD) and liver cirrhosis. Investment opportunities in this market are focused on improving MRE technology for broader clinical use, enhancing the accuracy of disease staging, and increasing market access to healthcare facilities outside of major metropolitan centers. As demand for non-invasive diagnostic methods grows, MRE is expected to become an integral part of Australia`s healthcare landscape.
Magnetic Resonance Elastography (MRE) is a relatively new diagnostic modality with applications in liver disease and cancer detection. Its use is subject to TGA approval as part of MRI device configurations. While not yet standard in all public hospitals, MRE is gaining recognition due to its non-invasive nature. The government funds pilot projects and research studies to validate such emerging technologies. Adoption into mainstream healthcare will depend on outcomes from cost-benefit analyses and clinical trials. Current policy supports the development of precision diagnostics, aligning MRE with national health objectives.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Magnetic Resonance Elastography (MRE) Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Magnetic Resonance Elastography (MRE) Market - Industry Life Cycle |
3.4 Australia Magnetic Resonance Elastography (MRE) Market - Porter's Five Forces |
3.5 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Magnetic Resonance Elastography (MRE) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Magnetic Resonance Elastography (MRE) Market Trends |
6 Australia Magnetic Resonance Elastography (MRE) Market, By Types |
6.1 Australia Magnetic Resonance Elastography (MRE) Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Hepatic Magnetic Resonance Elastography, 2021- 2031F |
6.1.4 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Breast Magnetic Resonance Elastography, 2021- 2031F |
6.1.5 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Brain Magnetic Resonance Elastography, 2021- 2031F |
6.1.6 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Skeletal Muscle Magnetic Resonance Elastography, 2021- 2031F |
6.2 Australia Magnetic Resonance Elastography (MRE) Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Diagnostic Imaging Centers, 2021- 2031F |
6.2.4 Australia Magnetic Resonance Elastography (MRE) Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 Australia Magnetic Resonance Elastography (MRE) Market Import-Export Trade Statistics |
7.1 Australia Magnetic Resonance Elastography (MRE) Market Export to Major Countries |
7.2 Australia Magnetic Resonance Elastography (MRE) Market Imports from Major Countries |
8 Australia Magnetic Resonance Elastography (MRE) Market Key Performance Indicators |
9 Australia Magnetic Resonance Elastography (MRE) Market - Opportunity Assessment |
9.1 Australia Magnetic Resonance Elastography (MRE) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Australia Magnetic Resonance Elastography (MRE) Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Magnetic Resonance Elastography (MRE) Market - Competitive Landscape |
10.1 Australia Magnetic Resonance Elastography (MRE) Market Revenue Share, By Companies, 2024 |
10.2 Australia Magnetic Resonance Elastography (MRE) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |